PMV Pharmaceuticals, Inc.
PMVP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001699382
No open-market purchases or sales by PMV Pharmaceuticals, Inc. insiders were filed in the last 90 days; 64 institutions reported holding it in 13F filings for Q2 2026, worth $45.9M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in PMV Pharmaceuticals, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 115
- −3 vs. Q3 2022
- Shares held
- 54.5M
- −3.63M (−6.2%) vs. Q3 2022
- Total value
- $474.5M
- −$217.8M (−31.5%) vs. Q3 2022
- New holders
- 13
- 35 more added
- Sold out
- 16
- 39 more reduced
2 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PMVP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 64 | $45.9M |
| Q1 2026 | 69 | $45.8M |
| Q4 2025 | 63 | $46.8M |
| Q3 2025 | 64 | $52.5M |
| Q2 2025 | 54 | $36.8M |
| Q1 2025 | 55 | $40.7M |
| Q4 2024 | 70 | $58.8M |
| Q3 2024 | 74 | $58.2M |
| Q2 2024 | 93 | $65.6M |
| Q1 2024 | 99 | $72.7M |
| Q4 2023 | 98 | $144.0M |
| Q3 2023 | 104 | $333.0M |
| Q2 2023 | 106 | $324.0M |
| Q1 2023 | 113 | $245.7M |
| Q4 2022 | 115 | $474.5M |
| Q3 2022 | 120 | $692.3M |
| Q2 2022 | 105 | $870.9M |
| Q1 2022 | 99 | $1.15B |
| Q4 2021 | 105 | $1.10B |
| Q3 2021 | 92 | $1.31B |
| Q2 2021 | 86 | $1.44B |
| Q1 2021 | 81 | $1.31B |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding PMV Pharmaceuticals, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Morgan Stanley | 1,139,262 | $9.91M | 0.00% | −174,641−13.3% | Reduced |
| Citadel Advisors LLC | 1,376,099 | $12.0M | 0.01% | +406,601+41.9% | Added |
| Alkeon Capital Management LLC | 1,385,267 | $12.1M | 0.09% | −131,979−8.7% | Reduced |
| Nextech Invest AG | 1,385,807 | $12.1M | 4.80% | 00.0% | Unchanged |
| Interwest Venture Management Co | 1,614,911 | $14.0M | 67.54% | 00.0% | Unchanged |
| Euclidean Capital LLC | 2,336,909 | $20.3M | 19.02% | 00.0% | Unchanged |
| Vanguard Group Inc | 2,753,606 | $24.0M | 0.00% | −680,359−19.8% | Reduced |
| Avoro Capital Advisors LLC | 3,060,000 | $26.6M | 0.40% | 00.0% | Unchanged |
| Boxer Capital, LLC | 3,163,795 | $27.5M | 1.48% | 00.0% | Unchanged |
| State Street Corp | 3,307,236 | $28.8M | 0.00% | −589,814−15.1% | Reduced |
| BlackRock Inc. | 3,451,367 | $30.0M | 0.00% | +91,044+2.7% | Added |
| JPMorgan Chase & Co | 4,096,551 | $35.6M | 0.01% | −609,548−13.0% | Reduced |
| RTW Investments, LP | 4,356,920 | $37.9M | 0.77% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 6,563,077 | $57.1M | 1.09% | 00.0% | Unchanged |
| IFP Advisors, Inc | 5 | – | – | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 0 | $0 | 0.00% | −1,710,265−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −85,553−100.0% | Sold out |
| Victory Capital Management Inc | 0 | $0 | 0.00% | −49,330−100.0% | Sold out |
| Ensign Peak Advisors, Inc | 0 | $0 | 0.00% | −34,718−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −29,676−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −28,189−100.0% | Sold out |
| Alps Advisors Inc | 0 | $0 | 0.00% | −24,898−100.0% | Sold out |
| HighVista Strategies LLC | 0 | $0 | 0.00% | −23,324−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −22,275−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −19,134−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −18,200−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −9,512−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −1,888−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −179−100.0% | Sold out |
| Howe & Rusling Inc | 0 | $0 | 0.00% | −72−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −11−100.0% | Sold out |
| Wipfli Financial Advisors LLC, | – | – | – | – | Not filed |
| FourThought Financial, LLC | – | – | – | – | Not filed |